BetterLife Pharma's market value is the price at which a share of BetterLife Pharma trades on a public exchange. It measures the collective expectations of BetterLife Pharma investors about its performance. BetterLife Pharma is trading at 0.085 as of the 18th of January 2025. This is a 13.33 percent increase since the beginning of the trading day. The stock's lowest day price was 0.085. With this module, you can estimate the performance of a buy and hold strategy of BetterLife Pharma and determine expected loss or profit from investing in BetterLife Pharma over a given investment horizon. Check out BetterLife Pharma Correlation, BetterLife Pharma Volatility and BetterLife Pharma Alpha and Beta module to complement your research on BetterLife Pharma.
Please note, there is a significant difference between BetterLife Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if BetterLife Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BetterLife Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BetterLife Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BetterLife Pharma's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BetterLife Pharma.
0.00
12/19/2024
No Change 0.00
0.0
In 31 days
01/18/2025
0.00
If you would invest 0.00 in BetterLife Pharma on December 19, 2024 and sell it all today you would earn a total of 0.00 from holding BetterLife Pharma or generate 0.0% return on investment in BetterLife Pharma over 30 days. BetterLife Pharma is related to or competes with Anavex Life, Annovis Bio, Iovance Biotherapeutics, Axsome Therapeutics, and Novavax. BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the t... More
BetterLife Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BetterLife Pharma's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BetterLife Pharma upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for BetterLife Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BetterLife Pharma's standard deviation. In reality, there are many statistical measures that can use BetterLife Pharma historical prices to predict the future BetterLife Pharma's volatility.
BetterLife Pharma appears to be out of control, given 3 months investment horizon. BetterLife Pharma secures Sharpe Ratio (or Efficiency) of 0.0682, which signifies that the company had a 0.0682% return per unit of risk over the last 3 months. By analyzing BetterLife Pharma's technical indicators, you can evaluate if the expected return of 0.68% is justified by implied risk. Please makes use of BetterLife Pharma's Risk Adjusted Performance of 0.0366, semi deviation of 7.82, and Coefficient Of Variation of 3041.9 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, BetterLife Pharma holds a performance score of 5. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and BetterLife Pharma are completely uncorrelated. Please check BetterLife Pharma's downside variance, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether BetterLife Pharma's price patterns will revert.
Auto-correlation
0.30
Below average predictability
BetterLife Pharma has below average predictability. Overlapping area represents the amount of predictability between BetterLife Pharma time series from 19th of December 2024 to 3rd of January 2025 and 3rd of January 2025 to 18th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BetterLife Pharma price movement. The serial correlation of 0.3 indicates that nearly 30.0% of current BetterLife Pharma price fluctuation can be explain by its past prices.
Correlation Coefficient
0.3
Spearman Rank Test
-0.31
Residual Average
0.0
Price Variance
0.0
BetterLife Pharma lagged returns against current returns
Autocorrelation, which is BetterLife Pharma otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BetterLife Pharma's otc stock expected returns. We can calculate the autocorrelation of BetterLife Pharma returns to help us make a trade decision. For example, suppose you find that BetterLife Pharma has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
BetterLife Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BetterLife Pharma otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BetterLife Pharma otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BetterLife Pharma otc stock over time.
Current vs Lagged Prices
Timeline
BetterLife Pharma Lagged Returns
When evaluating BetterLife Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BetterLife Pharma otc stock have on its future price. BetterLife Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BetterLife Pharma autocorrelation shows the relationship between BetterLife Pharma otc stock current value and its past values and can show if there is a momentum factor associated with investing in BetterLife Pharma.
Other Information on Investing in BetterLife OTC Stock
BetterLife Pharma financial ratios help investors to determine whether BetterLife OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BetterLife with respect to the benefits of owning BetterLife Pharma security.